CRT 2026
Late-Breaking Clinical Trial
Dongming Hou, MD, PhD
Visiting Professor
2nd Affiliated Hospital, Zhejiang Univ. School of Medicine, and Beijing Anzhen Hospital, Minnesota, United States
Disclosure(s): Genesis: Consulting Fees (e.g., advisory boards) (Ongoing)